BP
ELV icon

BBR Partners’s Elevance Health ELV Stock Holding History

BBR Partners’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-778
Closed -$375K – 194
2022
Q2 		$375K Hold
778
– – 0.04% 154
2022
Q1 		$382K Hold
778
– – 0.04% 160
2021
Q4 		$361K Hold
778
– – 0.04% 142
2021
Q3 		$290K Hold
778
– – 0.02% 176
2021
Q2 		$297K Sell
778
-112
-13% -$42.8K 0.02% 157
2021
Q1 		$319K Buy
890
+90
+11% +$28.9K 0.03% 163
2020
Q4 		$257K Buy
800
+22
+3% +$6.75K 0.02% 161
2020
Q3 		$209K Buy
+778
New +$209K 0.02% 170

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

BBR Partners's ELV Position: Q3 2022 in Review

BBR Partners sold out of Elevance Health (ELV) in Q3 2022, closing a stake of 778 shares — an estimated $375K sold.

BBR Partners first reported a position in ELV in Q3 2020 and held it in 8 quarters. The position peaked at $382K in Q1 2022. 1,445 funds tracked by Wall St. Rank hold ELV as of Q3 2022.

  • BBR Partners reported no remaining Elevance Health position as of Q3 2022 after selling out during the quarter.
  • BBR Partners sold 778 Elevance Health shares in Q3 2022, an estimated $375K.
  • BBR Partners first reported a position in Elevance Health in Q3 2020 and held it in 8 quarters.
  • BBR Partners's Elevance Health position peaked at $382K in Q1 2022.
  • 1,445 funds tracked by Wall St. Rank held Elevance Health as of Q3 2022.

Based on BBR Partners's 13F filing for Q3 2022, filed 10 Nov 2022.